A Convenient Laboratory-Scale Synthesis Route Toward the PPARα Agonist Pemafibrate

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Pharmacology

Background:

• Pemafibrate is a selective peroxisome proliferator-activated receptor alpha (PPARα) agonist.
• Clinically approved for hyperlipidemia, it's also vital for metabolic and cardiovascular research.
• High commercial cost restricts its use in academic settings, especially for large-scale studies.

Purpose of the Study:

• To develop a practical and efficient laboratory-scale synthesis of pemafibrate.
• To provide a cost-effective route for obtaining multigram quantities of enantiopure pemafibrate.
• To facilitate academic research and exploration of novel applications for pemafibrate.

Main Methods:

• Adaptation and optimization of literature and patent protocols.
• Development of a six-step synthetic route.
• Focus on readily available and inexpensive starting materials.

Main Results:

• A convenient and high-yielding synthesis of pemafibrate was established.
• The procedure allows for multigram-scale production of enantiopure pemafibrate.
• The new route is straightforward and efficient.

Conclusions:

• The presented synthetic strategy offers a practical solution for accessing pemafibrate affordably.
• This facilitates its use in academic research and potential development of new therapeutic applications.
• The synthesis is scalable and cost-effective for researchers.